Onsdag 28 Oktober | 18:59:51 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

OssDsign Q3 - Catalyst positively surprises, but still a difficult climate

2022-11-23 07:53:00

Redeye is encouraged by the strong sales development, boosted by Catalyst contributing to c60% of US sales. While its spine product certainly positively surprised us, we emphasise a continuously challenging climate for elective surgeries and restricted hospital access, likely to depress sales in the medium term. We adjust our fair value range downwards following the report.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.